2.25 mg tirzepatide Semaglutide & Dosing Guide: to Units Chart Tirzepatide 2.125mg/B12 x 4 doses

The reduction in liver fat results from pleiotropic actions of FGF21, particularly suppressing caloric burden in the liver, reducing de novo lipogenesis, and increasing fat oxidation in the liver

Tirzepatide was FDA-approved in 2022 initially for type 2 diabetes management, and then also for weight loss

It works by binding to GHRH receptors on the pituitary gland, stimulating the body's own pulsatile release of growth hormone, which in turn raises IGF-1 levels

CDC Staff

A 2023 survey found that the average medical school devotes fewer than 10 hours to nutrition education across four years

Retatrutide produces faster weight reduction than any other approved or near-approval weight loss medication